NO20101615L - Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav. - Google Patents

Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Info

Publication number
NO20101615L
NO20101615L NO20101615A NO20101615A NO20101615L NO 20101615 L NO20101615 L NO 20101615L NO 20101615 A NO20101615 A NO 20101615A NO 20101615 A NO20101615 A NO 20101615A NO 20101615 L NO20101615 L NO 20101615L
Authority
NO
Norway
Prior art keywords
cell proliferation
producing
methods
same
inhibiting cell
Prior art date
Application number
NO20101615A
Other languages
English (en)
Inventor
Albert L Rubin
Kanti Jain
Barry Smith
Kurt Stenzel
Shirin Asina
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20101615L publication Critical patent/NO20101615L/no
Application filed by Rogosin Inst filed Critical Rogosin Inst

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Det beskrives fast agarosebelagt, agarose-inneholdende perler som inneholder raskt prolifererende celler som, når begrenset ved å være fanget i nevnte perle, produserer et materiale som undertrykker celleproliferasjon. Videre beskrives fremgangsmåter for å fremstille en agarosebelagt, agarose-inneholdende perle som inneholder raskt proliferende celler. Det beskrives også fremgangsmåter for å undertrykke proliferasjon av celler i et individ i behov derav. Det beskrives også materialer nyttig i å undertrykke proliferasjon av celler, og fremgangsmåte for å stimulere produksjon av et materiale som har en celleproliferasjonsinhiberende effekt, og fremgangsmåte for å undertrykke proliferasjon av celler i et individ i behov derav.
NO20101615A 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav. NO20101615L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/188,476 US6224912B1 (en) 1996-04-03 1998-11-09 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
PCT/US1999/026413 WO2000027207A1 (en) 1998-11-09 1999-11-09 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof

Publications (1)

Publication Number Publication Date
NO20101615L true NO20101615L (no) 2001-07-05

Family

ID=22693322

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20012152A NO20012152L (no) 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20012152A NO20012152L (no) 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav

Country Status (19)

Country Link
US (4) US6224912B1 (no)
EP (1) EP1128731B1 (no)
JP (2) JP4294223B2 (no)
KR (3) KR20040075922A (no)
CN (1) CN1325271A (no)
AT (1) ATE446678T1 (no)
AU (1) AU769411B2 (no)
CA (1) CA2334483C (no)
DE (1) DE69941599D1 (no)
DK (1) DK1128731T3 (no)
EG (1) EG24212A (no)
ES (1) ES2335723T3 (no)
HK (1) HK1039439A1 (no)
IL (3) IL139704A0 (no)
NO (2) NO20012152L (no)
NZ (1) NZ511220A (no)
PT (1) PT1128731E (no)
RU (2) RU2268735C1 (no)
WO (1) WO2000027207A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1418228E (pt) * 1994-01-13 2006-09-29 Rogosin Inst Processo de preparacao de uma biblioteca multicombinatoria de vectores de expressao de genes de anticorpos.
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US20050053586A1 (en) * 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
US20060121077A1 (en) * 2004-11-11 2006-06-08 Lawrence Gazda Method for treating patients with implants of islets which have been kept in long term, in vitro culture
CA2622529C (en) * 2005-09-26 2014-02-18 Lawrence Gazda Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof
JP4891840B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
JP4891841B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
JP4887221B2 (ja) 2007-06-08 2012-02-29 浜松ホトニクス株式会社 分光モジュール
WO2008149940A1 (ja) 2007-06-08 2008-12-11 Hamamatsu Photonics K.K. 分光モジュール
KR20100017083A (ko) 2007-06-08 2010-02-16 하마마츠 포토닉스 가부시키가이샤 분광 모듈
EP2063238B1 (en) 2007-06-08 2018-08-22 Hamamatsu Photonics K.K. Spectroscope
US8049887B2 (en) 2007-06-08 2011-11-01 Hamamatsu Photonics K.K. Spectroscopic module
MX2010001993A (es) 2007-08-23 2010-03-11 Intrexon Corp Metodos y composiciones para diagnosticar una enfermedad.
CA2715080C (en) 2007-09-28 2021-09-28 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
EP2116828A4 (en) 2008-03-04 2014-01-08 Hamamatsu Photonics Kk SPEKTROSKOPMODUL
JP5207938B2 (ja) 2008-05-15 2013-06-12 浜松ホトニクス株式会社 分光モジュール及び分光モジュールの製造方法
JP2009300418A (ja) 2008-05-15 2009-12-24 Hamamatsu Photonics Kk 分光モジュール
JP5415060B2 (ja) 2008-05-15 2014-02-12 浜松ホトニクス株式会社 分光モジュール
JP5205238B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5512961B2 (ja) 2008-05-15 2014-06-04 浜松ホトニクス株式会社 分光モジュール及びその製造方法
JP5205241B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5205240B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュールの製造方法及び分光モジュール
EP2412800A1 (en) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US8572921B2 (en) * 2009-03-27 2013-11-05 Davinci Roofscapes, Llc One piece hip and ridge shingle
US20120156246A1 (en) * 2010-06-16 2012-06-21 Bamdad Cynthia C Reprogramming cancer cells
KR20130100122A (ko) * 2010-08-12 2013-09-09 얀센 바이오테크 인코포레이티드 췌장 내분비 전구 세포를 이용한 당뇨병의 치료
PL2777398T3 (pl) 2010-11-23 2017-09-29 The Rogosin Institute, Inc. Sposób izolowania opornych na środek chemioterapeutyczny komórek rakowych o właściwościach komórek macierzystych
RU2591518C2 (ru) 2012-01-31 2016-07-20 Де Рогозин Инститьют Инк. Усовершенствованный способ получения макрогранул
US10697972B2 (en) 2016-01-12 2020-06-30 Bioatla, Llc Diagnostics using conditionally active antibodies
EP3403098B1 (en) 2016-01-12 2021-09-22 BioAtla, Inc. Diagnostics using conditionally active antibodies
KR200485213Y1 (ko) 2016-11-02 2017-12-07 고수한 높이 조절이 가능한 조립식평상
AU2019215096A1 (en) * 2018-02-02 2020-08-06 Wake Forest University Health Sciences Organoids related to immunotherapy and methods of preparing and using the same

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865689A (en) 1972-11-09 1975-02-11 Hoffmann La Roche Method of producing carcinoembryonic antigens
US4285930A (en) 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4409331A (en) 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
DE3032931C2 (de) 1980-09-02 1982-07-29 Robert Bürkle GmbH & Co, 7290 Freudenstadt Verfahren und Anordnung zur Herstellung von Mehrschicht-Leiterplatten
SE441009B (sv) 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
JPS5933223A (ja) 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
CA1196862A (en) 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4680174A (en) 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
JPS6118721A (ja) 1984-07-06 1986-01-27 Kyowa Hakko Kogyo Co Ltd 新規抗腫瘍性物質
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US5618715A (en) 1985-12-20 1997-04-08 Oncogen Limited Partnership Oncostatin M and novel compositions having anti-neoplastic activity
SE8604684L (sv) 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JPS6463395A (en) 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
JPH0216994A (ja) 1988-07-05 1990-01-19 Nippon Mining Co Ltd 細胞増殖阻害因子及びその製造方法
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
DK0585368T3 (da) 1991-04-25 1998-03-16 Univ Brown Res Found Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter
US5800829A (en) 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
DK0802800T3 (da) 1993-08-12 2002-10-07 Neurotech Sa Biokompatible immunoisolatoriske kapsler indeholdende genetisk ændrede celler for levering af biologisk aktive molekyler
PT1418228E (pt) * 1994-01-13 2006-09-29 Rogosin Inst Processo de preparacao de uma biblioteca multicombinatoria de vectores de expressao de genes de anticorpos.
EP0769932B1 (en) 1994-07-08 1998-10-14 Baxter International Inc. Implanted device containing tumor cells for the treatment of cancer
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
DE69725317T2 (de) 1996-04-03 2004-07-29 The Rogosin Institute Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation

Also Published As

Publication number Publication date
NO20012152D0 (no) 2001-05-02
US6808705B2 (en) 2004-10-26
IL177967A (en) 2010-12-30
DK1128731T3 (da) 2010-01-25
ES2335723T3 (es) 2010-03-31
US20030143739A1 (en) 2003-07-31
US20030143281A1 (en) 2003-07-31
IL139704A0 (en) 2002-02-10
EP1128731B1 (en) 2009-10-28
CA2334483C (en) 2012-01-10
NZ511220A (en) 2003-12-19
US20020168415A1 (en) 2002-11-14
CA2334483A1 (en) 2000-05-18
HK1039439A1 (zh) 2002-04-26
CN1325271A (zh) 2001-12-05
US7041504B2 (en) 2006-05-09
IL177967A0 (en) 2006-12-31
WO2000027207A8 (en) 2000-09-21
KR20020013465A (ko) 2002-02-20
WO2000027207A1 (en) 2000-05-18
RU2236855C2 (ru) 2004-09-27
ATE446678T1 (de) 2009-11-15
RU2004115040A (ru) 2005-10-27
IL139704A (en) 2006-12-31
NO20012152L (no) 2001-07-05
US6224912B1 (en) 2001-05-01
EG24212A (en) 2008-10-28
RU2268735C1 (ru) 2006-01-27
JP4294223B2 (ja) 2009-07-08
US6818230B2 (en) 2004-11-16
AU769411B2 (en) 2004-01-29
PT1128731E (pt) 2010-02-02
DE69941599D1 (de) 2009-12-10
KR20050055797A (ko) 2005-06-13
EP1128731A4 (en) 2003-06-04
EP1128731A1 (en) 2001-09-05
AU1472600A (en) 2000-05-29
JP2005343899A (ja) 2005-12-15
JP2002529060A (ja) 2002-09-10
KR20040075922A (ko) 2004-08-30

Similar Documents

Publication Publication Date Title
NO20101615L (no) Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.
CA2291222A1 (en) Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
WO1998025598A3 (en) Methods and pharmaceutical compositions for inhibiting tumour cell growth
WO1998053618A3 (en) Enhanced cellular layout for cdma networks having six-sectored cells
NZ334034A (en) Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype
AU7585598A (en) Raf kinase inhibitors
WO1998007830A3 (en) COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
EP1024502A4 (en) ELECTROLYTE COMPOSITION, ELECTROLYTE AND METHOD FOR THE PRODUCTION THEREOF, AND THE CELL CONTAINING IT
NO975557D0 (no) Immortalisering og dismortalisering av celler
AU3040300A (en) Fluorescent dyes for solid phase and solution phase screening
WO2002030465A3 (en) Compositions that inhibit proliferation of cancer cells
HUP0002101A3 (en) Fluoroether compositions, process for producing them and methods for inhibiting their degradation
MX9101968A (es) Algoritmo de distribucion para celulas de radiotelefono alargadas.
NO994309L (no) Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner
TR199801954T2 (xx) Eprosartan dihidrat ve �retimi ve form�lasyonu i�in bir proses.
IL142720A0 (en) Water-miscible pharmaceutical compositions of paclitaxel
AU3052799A (en) Pharmaceutical compositions comprising erythropoietin for treatment of cancer
WO2003024405A3 (en) Methods and compositions for inhibiting the proliferation of prostate cancer cells
AU1337783A (en) New fibrionoltic enzymes
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
IN187760B (no)
EP1328279A4 (en) COMPOSITIONS OF LIGNIN AND METHOD FOR THEIR PREPARATION AND USE
SI1244614T1 (en) Tryptase inhibitors
MXPA00006072A (es) Metodos y composiciones para inhibir el crecimiento de celulas tumorales.
EP1518930A3 (en) Methods and compositions for inhibiting neoplastic cell growth

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application